NEU neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-24

  1. 2,559 Posts.
    lightbulb Created with Sketch. 2664
    As I have said in previous post instos now own at least 58% of NEU and the weak handed retail shareholders keep selling to the instos .I know a lot of the non insto shareholders in the top 20 .and it is fair to say they are all interested in an exit from the company at a reasonable premium to the existing price .I know there has been a lot of talk on how much the company is worth but in my mind the small shareholders have next to no influence of the potential takeover price ,once the suitor has 50.1% the small shareholders can whistle dixy on how much the company is worth .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.24
Change
0.385(3.00%)
Mkt cap ! $1.652B
Open High Low Value Volume
$13.15 $13.37 $12.92 $4.345M 331.2K

Buyers (Bids)

No. Vol. Price($)
9 230 $13.22
 

Sellers (Offers)

Price($) Vol. No.
$13.24 288 9
View Market Depth
Last trade - 12.23pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.